Comparison of treatment response, remission rate and drug adherence in polyarticular juvenile idiopathic arthritis patients treated with etanercept, adalimumab or tocilizumab
Crossref DOI link: https://doi.org/10.1186/s13075-016-1170-3
Published Online: 2016-11-24
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Horneff, Gerd
Klein, Ariane
Klotsche, Jens
Minden, Kirsten
Huppertz, Hans-Iko
Weller-Heinemann, Frank
Kuemmerle-Deschner, Jasmin
Haas, Johannes-Peter
Hospach, Anton
Funding for this research was provided by:
Pfizer UK
AbbVie Deutschland
Roche